{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Participants with durable grafts. Graft durability was assessed by complete blood count (CBC) and differential analysis at 12 months post-transplantation.\n\nThis study was terminated early and analysis was not done.","groups":[{"description":"Mobilization with Granulocyte Colony Stimulating Factor (G-CSF) (10 µg/kg once a day) for 5 days. Patients received once daily plerixafor treatment (240 mg/kg) in the evening (10 to 11 hours prior to apheresis) for up to 3 days if peripheral blood CD34+ cell counts on Day 5 met the entry criteria. Morning doses of G-CSF (10 µg/kg) continued throughout apheresis.","id":"OG000","title":"All Patients"}],"populationDescription":"This study was terminated early and analysis was not done.","reportingStatus":"POSTED","timeFrame":"13 months","title":"Graft Durability at 12 Months After Transplantation","type":"SECONDARY"}